BeiGene Ltd vs HutchMed (China) Ltd
A side-by-side look at two Chinese stocks — live quote, valuation, growth, listing venue, dual-listing and delisting status, and the WealthyTec Rank. A factual comparison for orientation, not investment advice.
| Metric | BeiGene Ltd 6160.HK · Hong Kong 183.50 HKD | HutchMed (China) Ltd HCM · US (ADR) 11.07 USD |
|---|---|---|
| Day change | +0.88% | +0.82% |
| Market cap | $— | $— |
| P/E (TTM) | — | 21.3 |
| 2y EPS CAGR | — | +108.2% |
| WealthyTec Rank | — | 8.0 |
| Rank within sector | n/a | #4 of 31 |
| Listing venue | HKEX | NYSE / NASDAQ (ADR) |
| Other listings | n/a | n/a |
| Delisting filings | None on record | None on record |
| Sector | Health Care | Health Care |
| Industry | Pharma & Biotech | Pharma & Biotech |